In our study, we also found that CD4+T cells and CD8+T cells in the death group were lower via the univariable analysis, and further multivariable analysis revealed that more CD8+T cells might improve survival prognosis in MDA5+DM patients. This evidence concerns the gene CD4 and dermatomyositis.